DIGITAL ADVANTAGE FOR LIFE SCIENCES
A modern and open technology platform for life sciences
Agile and safe clinical trials are key to faster drug development
The need to synthesize data from different sources increases the risk of regulatory non-compliance for pharma companies. As a result, they face an exponential increase in clinical research and development costs, sub-optimal clinical trial execution, and delays in launching new, approved drugs. TCS ADD™ enables digital ecosystems, simplifies data complexity, and drives innovation in clinical trials to bring drugs to market faster.
Quicker decision-making with real-time access to data
Faster drug registration with adaptive trial design
Improved data quality with advanced analytics
Unified platform for sites, patients, and regulators
TCS helped Roche roll out an eConsent solution
A ready-to-use, interoperable metadata-driven AI platform that automates study build, enables robust governance, and rapidly transforms and generates submission-ready datasets
A one-stop, integrated, cloud-deployed, self-service solution that caters to all data management needs of pharma
TCS ADD Analytics and Insights platform leverages AI and ML in clinical trials to enable faster study start-ups and achieve targeted study interventions.
Read how TCS ADD Connected Clinical Trials, a decentralized clinical trials platform, makes trials patient-centric, site friendly, and digital by default.
TCS ADD Safety, an AI platform for pharmacovigilance, can help firms enable audit readiness with transparent algorithms. See how our solution can help you.
Read how the AI platform accelerates drug regulatory compliance that helps improve operational efficiencies and enables taking informed strategic decisions.
TCS ADD™ wins at 2021 India Pharma Awards
TCS ADD™ Safety wins 2020/21 Awards.AI for using AI to reimagine pharmacovigilance
TCS wins Best Patient-facing Technology Initiative at the Citeline Awards 2020
TCS Recognized as a Leader in IDC MarketScape for Life Science R&D Decentralized Clinical